Understanding Your Treatment Options for Advanced Prostate
October 28th 2024Panelists discuss how a comprehensive treatment approach for advanced prostate cancer involves considering various patient-specific factors, the transformative role of androgen receptor pathway inhibitors (ARPIs), and the necessity of early and aggressive intervention, while emphasizing the importance of clear communication between oncologists and patients regarding treatment expectations and options.
Watch
Navigating Post-Surgery Recovery
October 28th 2024Panelists discuss how assessing patients' responses to treatment and addressing common adverse effects are essential for effective management of advanced prostate cancer, while also highlighting the importance of patient education and preparation before starting therapy.
Watch
What to Expect from Your Healthcare Team
October 22nd 2024Nisha Mohindra, MD, and Christopher Towe, MD, define the term “multidisciplinary team” and explain why early-stage NSCLC care requires a diverse group of specialists. They also discuss the function and value of this collaborative model in guiding treatment plans. Sponsored by Bristol Myers Squibb.
Watch
Understanding Neoadjuvant Therapy for Early-Stage Non-Small Cell Lung Cancer
October 22nd 2024Nisha Mohindra, MD, and Christopher Towe, MD, discuss what early-stage non-small cell lung cancer treatment options have looked like in the past and a more recent treatment option, neoadjuvant therapy. Sponsored by Bristol Myers Squibb.
Watch
What is Early-Stage Non-Small Cell Lung Cancer?
October 22nd 2024After Danielle Hicks introduces the panelists, Nisha Mohindra, MD, and Christopher Towe, MD, provide an overview of what an early-stage non-small cell lung cancer diagnosis means and how it is diagnosed. Sponsored by Bristol Myers Squibb.
Watch